Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on November 17, 2004, to announce a proposed amendment to its 2000 Long-Term Incentive Plan (2000 Plan). This amendment, if approved by shareholders, would introduce a one-time Option Exchange Program. This program allows eligible employees to exchange certain existing stock options for a reduced number of new options with an exercise price set at the fair market value on the grant date of the replacement options. The primary purpose of this program appears to be a form of equity compensation restructuring. By allowing employees to exchange higher-priced, potentially underwater options for new ones at current market value, the company aims to re-energize its workforce and retain key talent. The filing also notes that a preliminary proxy statement has been submitted to the SEC, outlining a special shareholder meeting to vote on this proposed amendment, emphasizing that the amendment's effectiveness is contingent on shareholder approval.
Key Highlights
- 1Regeneron is proposing an amendment to its 2000 Long-Term Incentive Plan to create a one-time Option Exchange Program.
- 2The program allows eligible employees to exchange certain existing stock options for new options.
- 3Replacement options will be for a lesser number than the original options exchanged.
- 4The exercise price of the replacement options will be set at the fair market value of the common stock on the grant date of the new options.
- 5Shareholder approval is required for the amendment to become effective.
- 6A preliminary proxy statement has been filed with the SEC in anticipation of a shareholder meeting to vote on the amendment.